Insider filing · UTHR
Paul A Mahon
EVP & GENERAL COUNSEL
profile →
United Therapeutics Corporation
UTHR · Healthcare · 343 filings in 24 months
ticker →
Paul A Mahon sold $4.5M of United Therapeutics (UTHR)
Executed Jun 4, disclosed Jun 4, the same day.
Value, as filed
$4.5M
8,300 sh across 8 lots
Executed
Jun 4
the trade date, as filed
Disclosed
Jun 4
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PMPaul A Mahon (EVP & GENERAL COUNSEL) filed 24 Form 4 reports in the trailing twelve months (0 purchases, 24 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $5.5M of UTHR (10,742 sh across 4 lots, as filed), executed Dec 24 2025.
The name
UTHRHealthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Paul A Mahon in UTHR
UTHRSALE
United Therapeutics Corporation
$4.1M8,175 sh across 6 lots
Exec Sep 17
Filed Sep 18 · 4:40 PM ET UTHRSALE United Therapeutics Corporation $4.3M
8,180 sh across 8 lots
Exec Aug 20
Filed Aug 21 · 4:43 PM ET UTHRSALE United Therapeutics Corporation $4.3M
8,300 sh across 8 lots
Exec Aug 6
Filed Aug 6 · 4:35 PM ET UTHRSALE United Therapeutics Corporation $4.3M
8,100 sh across 6 lots
Exec Jul 16
Filed Jul 16 · 4:30 PM ET UTHRSALE United Therapeutics Corporation $4.6M
8,300 sh across 9 lots
Exec Jul 2
Filed Jul 2 · 4:32 PM ET UTHRSALE United Therapeutics Corporation $4.3M
7,983 sh across 9 lots
Exec Jun 18
Filed Jun 18 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $4.6M
8,180 sh across 8 lots
Exec May 21
Filed May 21 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $4.8M
8,150 sh across 6 lots
Exec May 7
Filed May 7 · 5:30 PM ET